Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Masui

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Diabetologia|January 17, 2007
Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitorH Noguchi, Y Nakai, M Ueda, et al.
Proteins|January 1, 1992
Functional implications of interleukin-1 beta based on the three-dimensional structureB Veerapandian, G L Gilliland, R Raag, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 15, 2001
Interleukin-1beta enhances retinoic acid-mediated expression of bone-type alkaline phosphatase in rat IEC-6 cellsT Nikawa, M Ikemoto, K Tokuoka, et al.
Alimentary Pharmacology & Therapeutics|May 12, 2000
Protective role of intracellular glutathione against nitric oxide-induced necrosis in rat gastric mucosal cellsY Naito, T Yoshikawa, Y Boku, et al.
The Journal of Antibiotics|January 1, 1992
WS-7338, new endothelin receptor antagonists isolated from Streptomyces sp. No. 7338. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activitiesS Miyata, M Hashimoto, Y Masui, et al.
Biochemistry|March 3, 1992
Stable isotope aided nuclear magnetic resonance study to investigate the receptor-binding site of human interleukin 1 betaS Tate, Y Kikumoto, S Ichikawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 4, 2011
Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosisS Noda, Y Asano, N Aozasa, et al.
Biofactors (Oxford, England)|March 29, 2001
Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia/reoxygenation injuryN Fujita, H Manabe, N Yoshida, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiencyN Murakami, J Fukata, T Usui, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Adrenocorticotropic hormone-releasing activities of interleukins in a homologous in vivo systemY Naito, J Fukata, T Tominaga, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Diabetologia|January 17, 2007
Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitorH Noguchi, Y Nakai, M Ueda, et al.
Proteins|January 1, 1992
Functional implications of interleukin-1 beta based on the three-dimensional structureB Veerapandian, G L Gilliland, R Raag, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 15, 2001
Interleukin-1beta enhances retinoic acid-mediated expression of bone-type alkaline phosphatase in rat IEC-6 cellsT Nikawa, M Ikemoto, K Tokuoka, et al.
Alimentary Pharmacology & Therapeutics|May 12, 2000
Protective role of intracellular glutathione against nitric oxide-induced necrosis in rat gastric mucosal cellsY Naito, T Yoshikawa, Y Boku, et al.
The Journal of Antibiotics|January 1, 1992
WS-7338, new endothelin receptor antagonists isolated from Streptomyces sp. No. 7338. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activitiesS Miyata, M Hashimoto, Y Masui, et al.
Biochemistry|March 3, 1992
Stable isotope aided nuclear magnetic resonance study to investigate the receptor-binding site of human interleukin 1 betaS Tate, Y Kikumoto, S Ichikawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 4, 2011
Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosisS Noda, Y Asano, N Aozasa, et al.
Biofactors (Oxford, England)|March 29, 2001
Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia/reoxygenation injuryN Fujita, H Manabe, N Yoshida, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiencyN Murakami, J Fukata, T Usui, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Adrenocorticotropic hormone-releasing activities of interleukins in a homologous in vivo systemY Naito, J Fukata, T Tominaga, et al.
Pageof 15